Pharmacogenomic analysis basic associated observations panel - Blood or Tissue   78046-0

LOINC Code


LOINC code78046-0
namePharmacogenomic analysis basic associated observations panel - Blood or Tissue
statusTRIAL

Fully-Specified Name

componentPharmacogenomic analysis basic associated observations panel
property-
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
systemBld/Tiss
    Bld  =  Whole blood
    Tiss  =  Tissue, unspecified
scale-
method

Additional Names

short namePharmacogen basic assoc obs Pnl Bld/T

Basic Attributes

classPANEL.MOLPATH
type1  Laboratory

Panel Components

51963-7Medication assessed [ID]
48018-6Gene studied [ID]
48008-7Allele name [Identifier]
48013-7Genomic reference sequence [ID]
51958-7Transcript reference sequence [ID]
51971-0Gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method
51964-5Drug efficacy analysis overall interpretation

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

History/Usage

first released
last updated2.63
last change typeMIN  - change to field other than name

Related Names

Assoc
Blood
Molecular pathology
MOLPATH
Pan
Panel.molpath
Panl
Pharmacogen basic assoc obs Pnl
Pnl
Point in time
Random
Tissue
Tissue, unspecified
WB
Whole blood
Whole blood or Tissue

Copyright © 2023 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2023, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.